| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $203K | +5033.0% | — |
| R&D Expense | $54K | -63.4% | -75.6% |
| SG&A Expense | $1.9M | -11.1% | +71.4% |
| Operating Income | -$1.8M | +40.7% | +9.0% |
| Pre-tax Income | -$3.9M | +77.6% | +31.7% |
| Net Income | -$3.9M | +77.6% | +31.7% |
| EPS (Basic) | -$1.56 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $17.7M | +22.9% | -10.0% |
| Current Assets | $18.3M | -7.2% | -17.6% |
| Total Assets | $18.4M | -7.2% | -19.6% |
| Current Liabilities | $1.0M | +8.1% | +205.7% |
| Total Liabilities | $1.7M | -7.5% | -82.6% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.9M | — | — |
| Investing Cash Flow | -$17.6M | — | — |
| Financing Cash Flow | $5.3M | — | — |
| +86.1% |
| -134.1% |
| EPS (Diluted) | -$1.56 | +86.1% | -134.1% |
| $16.1M |
| -6.9% |
| +25.5% |